Arkolith/Insider Trading/BIIB/Form 4

Murphy Nicole

Head of Pharm Ops and TechBIOGEN INC. (BIIB) · full profile →Form 4 · filed Feb 17, 2026
Net Buying
Open-Market Buys
$585
Open-Market Sells
$0
Net Open-Market Flow
$585
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 12, 2026Buy(P)3$195.04$58520K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 13, 2026Grant(A)11K—$011K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000875045-26-000033) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML